PSMA-targeted Docetaxel Nanoparticles BIND-014

Known as: BIND-014 
A proprietary preparation of polymeric nanoparticles containing the second-generation taxane docetaxel, targeted to prostate-specific membrane… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Importance Preferential delivery of docetaxel to tumors by prostate-specific membrane antigen (PSMA)-targeted nanoparticles is… (More)
  • table 1
  • table 2
  • figure 2
  • figure 1
  • figure 3
Is this relevant?
2016
2016
PURPOSE First-in-human phase I trial to determine the safety, pharmacokinetics, and antitumor activity of BIND-014, a novel… (More)
Is this relevant?
Review
2014
Review
2014
Recent advances in nanotechnology and biotechnology have contributed to the development of engineered nanoscale materials as… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Review
2014
Review
2014
Cancer nanotherapeutics are progressing at a steady rate; research and development in the field has experienced an exponential… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
The US Food and Drug Administration in May approved Elelyso (taliglucerase alfa), an enzyme produced in genetically engineered… (More)
Is this relevant?
Review
2012
Review
2012
The application of nanotechnology in medicine is offering many exciting possibilities in healthcare. Engineered nanoparticles… (More)
Is this relevant?
Review
2011
Review
2011
Nanoparticles (NPs) have become an important tool in many industries including healthcare. The use of NPs for drug delivery and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?